Literature DB >> 25531451

Patients' expectations of the benefits and harms of treatments, screening, and tests: a systematic review.

Tammy C Hoffmann1, Chris Del Mar2.   

Abstract

IMPORTANCE: Unrealistic patient expectations of the benefits and harms of interventions can influence decision making and may be contributing to increasing intervention uptake and health care costs.
OBJECTIVE: To systematically review all studies that have quantitatively assessed patients' expectations of the benefits and/or harms of any treatment, test, or screening test. EVIDENCE REVIEW: A comprehensive search strategy was used in 4 databases (MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, PsycINFO) up to June 2013, with no language or study type restriction. We also ran cited reference searches of included studies and contacted experts and study authors. Two researchers independently evaluated methodological quality and extracted participants' estimates of benefit and harms and authors' contemporaneous estimates.
FINDINGS: Of the 15,343 records screened, 36 articles (from 35 studies) involving a total of 27,323 patients were eligible. Fourteen studies focused on a screen, 15 on treatment, 3 a test, and 3 on treatment and screening. More studies assessed only benefit expectations (22 [63%]) than benefit and harm expectations (10 [29%]) or only harm (3 [8%]). Fifty-four outcomes (across 32 studies) assessed benefit expectations: of the 34 outcomes with overestimation data available, the majority of participants overestimated benefit for 22 (65%) of them. For 17 benefit expectation outcomes, we could not calculate the proportion of participants who overestimated or underestimated, although for 15 (88%) of these, study authors concluded that participants overestimated benefits. Expectations of harm were assessed by 27 outcomes (across 13 studies): underestimation data were available for 15 outcomes and the majority of participants underestimated harm for 10 (67%) of these. A correct estimation by at least 50% of participants only occurred for 2 outcomes about benefit expectations and 2 outcomes about harm expectations. CONCLUSIONS AND RELEVANCE: The majority of participants overestimated intervention benefit and underestimated harm. Clinicians should discuss accurate and balanced information about intervention benefits and harms with patients, providing the opportunity to develop realistic expectations and make informed decisions.

Entities:  

Mesh:

Year:  2015        PMID: 25531451     DOI: 10.1001/jamainternmed.2014.6016

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  153 in total

1.  Effects of personalized colorectal cancer risk information on laypersons' interest in colorectal cancer screening: The importance of individual differences.

Authors:  Paul K J Han; Christine W Duarte; Susannah Daggett; Andrea Siewers; Bill Killam; Kahsi A Smith; Andrew N Freedman
Journal:  Patient Educ Couns       Date:  2015-07-19

2.  Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.

Authors:  Jeanne S Mandelblatt; Natasha K Stout; Clyde B Schechter; Jeroen J van den Broek; Diana L Miglioretti; Martin Krapcho; Amy Trentham-Dietz; Diego Munoz; Sandra J Lee; Donald A Berry; Nicolien T van Ravesteyn; Oguzhan Alagoz; Karla Kerlikowske; Anna N A Tosteson; Aimee M Near; Amanda Hoeffken; Yaojen Chang; Eveline A Heijnsdijk; Gary Chisholm; Xuelin Huang; Hui Huang; Mehmet Ali Ergun; Ronald Gangnon; Brian L Sprague; Sylvia Plevritis; Eric Feuer; Harry J de Koning; Kathleen A Cronin
Journal:  Ann Intern Med       Date:  2016-01-12       Impact factor: 25.391

3.  How Do Older Adults Consider Age, Life Expectancy, Quality of Life, and Physician Recommendations When Making Cancer Screening Decisions? Results from a National Survey Using a Discrete Choice Experiment.

Authors:  Ellen M Janssen; Craig E Pollack; Cynthia Boyd; John F P Bridges; Qian-Li Xue; Antonio C Wolff; Nancy L Schoenborn
Journal:  Med Decis Making       Date:  2019-06-21       Impact factor: 2.583

4.  Measuring Hospital-Acquired Complications Associated With Low-Value Care.

Authors:  Tim Badgery-Parker; Sallie-Anne Pearson; Susan Dunn; Adam G Elshaug
Journal:  JAMA Intern Med       Date:  2019-04-01       Impact factor: 21.873

5.  The complicated 'Yes': Decision-making processes and receptivity to lung cancer screening among head and neck cancer survivors.

Authors:  Aaron T Seaman; Kimberly Dukes; Richard M Hoffman; Alan J Christensen; Nicholas Kendell; Andrew L Sussman; Miriam Veléz-Bermúdez; Robert J Volk; Nitin A Pagedar
Journal:  Patient Educ Couns       Date:  2018-04-22

6.  When Religion and Medicine Clash: Non-beneficial Treatments and Hope for a Miracle.

Authors:  Philip M Rosoff
Journal:  HEC Forum       Date:  2019-06

Review 7.  Imaging-based screening: maximizing benefits and minimizing harms.

Authors:  Jessica C Germino; Joann G Elmore; Ruth C Carlos; Christoph I Lee
Journal:  Clin Imaging       Date:  2015-06-12       Impact factor: 1.605

8. 

Authors:  Roland Grad; Guylène Thériault; Harminder Singh; James A Dickinson; Olga Szafran; Neil R Bell
Journal:  Can Fam Physician       Date:  2019-08       Impact factor: 3.275

9.  Lay Beliefs About the Accuracy and Value of Cancer Screening.

Authors:  Megan C Roberts; Rebecca A Ferrer; Katharine A Rendle; Sarah C Kobrin; Stephen H Taplin; Bradford W Hesse; William M P Klein
Journal:  Am J Prev Med       Date:  2018-03-16       Impact factor: 5.043

10.  Scientific Quality of Health-Related Articles in Specialty Cannabis and General Newspapers in San Francisco.

Authors:  Ryan T Halvorson; Christopher C Stewart; Aishwarya Thakur; Stanton A Glantz
Journal:  J Health Commun       Date:  2018-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.